Phimume® Percutaneous Left Ventricular Assist System Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 250 participants.
Also called NCT06639321
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose supportive care
- Phase
- Not applicable
- Enrolled
- 250 participants
- Registry
-
NCT06639321
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT06639321. Randomized; no masking; primary purpose supportive care. Start 2024-10-14 (anticipated); primary completion 2025-11-14 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Phimume® Percutaneous Left Ventricular Assist System Study
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Percutaneous Ventricular Assist System
- Intervention (Device)
- extracorporeal membrane oxygenation (ECMO)
- Lead sponsor
- Shanghai NewMed Medical Co., Ltd.
- Collaborator
- Shanghai Phigine Medical Technology Co., Ltd.
Record details
- Record id
cardio:ct-nct06639321- Content hash
69c479fec986d049d69dc77666f6ca4e565c4348ec29bc92af677d1ed5516257